Your browser doesn't support javascript.
loading
Cardiology Encounters for Underrepresented Racial and Ethnic Groups with Human Immunodeficiency Virus and Borderline Cardiovascular Disease Risk.
Bloomfield, Gerald S; Hill, C Larry; Chiswell, Karen; Cooper, Linda; Gray, Shamea; Longenecker, Chris T; Louzao, Darcy; Marsolo, Keith; Meissner, Eric G; Morse, Caryn G; Muiruri, Charles; Thomas, Kevin L; Velazquez, Eric J; Vicini, Joseph; Pettit, April C; Sanders, Gretchen; Okeke, Nwora Lance.
Afiliação
  • Bloomfield GS; Department of Medicine, Duke University School of Medicine, Durham, NC, USA. gerald.bloomfield@duke.edu.
  • Hill CL; Duke Clinical Research Institute, Duke University School of Medicine, 300 W. Morgan Street, Durham, NC, 27701, USA. gerald.bloomfield@duke.edu.
  • Chiswell K; Duke Clinical Research Institute, Duke University School of Medicine, 300 W. Morgan Street, Durham, NC, 27701, USA.
  • Cooper L; Duke Clinical Research Institute, Duke University School of Medicine, 300 W. Morgan Street, Durham, NC, 27701, USA.
  • Gray S; Department of Medicine, Medical University of South Carolina, Charleston, SC, USA.
  • Longenecker CT; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Louzao D; Division of Cardiology and Department of Global Health, University of Washington, Seattle, WA, USA.
  • Marsolo K; Duke Clinical Research Institute, Duke University School of Medicine, 300 W. Morgan Street, Durham, NC, 27701, USA.
  • Meissner EG; Duke Clinical Research Institute, Duke University School of Medicine, 300 W. Morgan Street, Durham, NC, 27701, USA.
  • Morse CG; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
  • Muiruri C; Department of Medicine, Medical University of South Carolina, Charleston, SC, USA.
  • Thomas KL; Wake Forest University Health Sciences, Winston-Salem, NC, USA.
  • Velazquez EJ; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
  • Vicini J; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Pettit AC; Duke Clinical Research Institute, Duke University School of Medicine, 300 W. Morgan Street, Durham, NC, 27701, USA.
  • Sanders G; Section of Cardiovascular Medicine, Yale University, New Haven, CT, USA.
  • Okeke NL; Department of Medicine, Vanderbilt University, Nashville, TN, USA.
Article em En | MEDLINE | ID: mdl-37160576
BACKGROUND: Underrepresented racial and ethnic groups (UREGs) with HIV have a higher risk of cardiovascular disease (CVD) compared with the general population. Referral to a cardiovascular specialist improves CVD risk factor management in high-risk individuals. However, patient and provider factors impacting the likelihood of UREGs with HIV to have an encounter with a cardiologist are unknown. METHODS: We evaluated a cohort of UREGs with HIV and borderline CVD risk (10-year risk ≥ 5% by the pooled cohort equations or ≥ 7.5% by Framingham risk score). Participants received HIV-related care from 2014-2020 at four academic medical centers in the United States (U.S.). Adjusted Cox proportional hazards regression was used to estimate the association of patient and provider characteristics with time to first ambulatory cardiology encounter. RESULTS: A total of 2,039 people with HIV (PWH) and borderline CVD risk were identified. The median age was 45 years (IQR: 36-50); 52% were female; and 94% were Black. Of these participants, 283 (14%) had an ambulatory visit with a cardiologist (17% of women vs. 11% of men, p < .001). In fully adjusted models, older age, higher body mass index (BMI), atrial fibrillation, multimorbidity, urban residence, and no recent insurance were associated with a greater likelihood of an encounter with a cardiologist. CONCLUSION: In UREGs with HIV and borderline CVD risk, the strongest determinants of a cardiology encounter were diagnosed CVD, insurance type, and urban residence. Future research is needed to determine the extent to which these encounters impact CVD care practices and outcomes in this population. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04025125.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article